Close

    LEPROSY

    • Date : 01/01/2023 - 31/12/2023

    Introduction

    • Cause: – Mycobacterium leprae.
    • Effect (clinical symptoms):- Hypo pigmented/copper skin patches with definite sensory loss. Multi Drug Treatment (MDT) is given to treat the patients. Special footwear, care is required for disability prevention.
    • Complications: – Disability due to loss of function/muscular weakness corresponding to the nerve involvement like claw hand, drop foots etc. Reconstructive Surgery is done to correct the disability.
    • Background of the Programme:-
      NLEP was launched by Govt. of India in 1983. The programme aim is early detection of cases and to achieve reduction in Grade-II disability.

    Range of Services/Facilities being provided

    • Anti Leprosy Drugs i.e. MDT are supplied Free of Cost and are available at all the District Hospitals and community health centers/PHCs where the patients have been registered. Micro Cellular Rubber (MCR) footwears are distributed to leprosy affected persons. Govt. of Haryana is also providing supportive Medicines, Splint & Crutches, self care kits etc. to the leprosy patients.
    • Free Re Constructive Surgeries for leprosy patients with disabilities.

    consolidated annual report 2021-22

    consolidated annual report 2022-23

    Note 2023-24

    Beneficiary:

    Anti Leprosy Drugs i.e. MDT are supplied Free of Cost and are available at all the District Hospitals and community health centers/PHCs where the patients have been registered.

    Benefits:

    Free Re Constructive Surgeries for leprosy patients with disabilities.